Fairfax India Holdings Corp (FIH.U.TO)
14.35
-0.17
(-1.17%)
USD |
TSX |
Jun 28, 16:00
Fairfax India Holdings Enterprise Value: 2.534B for June 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 28, 2024 | 2.534B |
June 27, 2024 | 2.557B |
June 26, 2024 | 2.538B |
June 25, 2024 | 2.583B |
June 24, 2024 | 2.615B |
June 21, 2024 | 2.642B |
June 20, 2024 | 2.466B |
June 19, 2024 | 2.471B |
June 18, 2024 | 2.488B |
June 17, 2024 | 2.480B |
June 14, 2024 | 2.480B |
June 13, 2024 | 2.473B |
June 12, 2024 | 2.481B |
June 11, 2024 | 2.472B |
June 10, 2024 | 2.475B |
June 07, 2024 | 2.473B |
June 06, 2024 | 2.446B |
June 05, 2024 | 2.439B |
June 04, 2024 | 2.461B |
June 03, 2024 | 2.522B |
May 31, 2024 | 2.527B |
May 30, 2024 | 2.477B |
May 29, 2024 | 2.507B |
May 28, 2024 | 2.499B |
May 27, 2024 | 2.498B |
Date | Value |
---|---|
May 24, 2024 | 2.498B |
May 23, 2024 | 2.489B |
May 22, 2024 | 2.489B |
May 21, 2024 | 2.512B |
May 17, 2024 | 2.527B |
May 16, 2024 | 2.546B |
May 15, 2024 | 2.508B |
May 14, 2024 | 2.494B |
May 13, 2024 | 2.491B |
May 10, 2024 | 2.491B |
May 09, 2024 | 2.504B |
May 08, 2024 | 2.502B |
May 07, 2024 | 2.512B |
May 06, 2024 | 2.534B |
May 03, 2024 | 2.554B |
May 02, 2024 | 2.595B |
May 01, 2024 | 2.594B |
April 30, 2024 | 2.598B |
April 29, 2024 | 2.583B |
April 26, 2024 | 2.587B |
April 25, 2024 | 2.619B |
April 24, 2024 | 2.596B |
April 23, 2024 | 2.592B |
April 22, 2024 | 2.592B |
April 19, 2024 | 2.577B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.332B
Minimum
Apr 02 2020
2.696B
Maximum
Dec 20 2019
2.237B
Average
2.323B
Median
Dec 05 2022
Enterprise Value Benchmarks
Fairfax Financial Holdings Ltd | 46.18B |
Cypherpunk Holdings Inc | 8.797M |
Armada Mercantile Ltd | 0.8291M |
New Frontier Ventures Inc | 0.4176M |
Xtacy Therapeutics Corp | 2.200M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -293.50M |
Revenue (Quarterly) | -294.14M |
EPS Diluted (Quarterly) | -2.17 |
Profit Margin (Quarterly) | 99.78% |
Earnings Yield | 6.06% |
Normalized Earnings Yield | 6.063 |